Recent Analyst Forecasts and Stock Ratings
Zevra Therapeutics, Inc. FAQ's
Zevra Therapeutics, Inc. has been rated by research analysts at Guggenheim, JMP Securities, Roth Capital, Maxim Group, H.C. Wainwright, Canaccord Genuity in the past 90 days.